Cycclone 

$0.04
0
+$0.02+83.5% Wednesday 20:00

Statistics

Day High
0.02
Day Low
0.02
52W High
0.15
52W Low
0.01
Volume
25,000
Avg. Volume
3,116
Mkt Cap
1.5M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Jan 6
$5.52
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Financials

-Profit Margin
Profitable
2022
2023
2024
0Revenue
1.57MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CYCL. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Zai Lab Limited
ZLAB
Mkt Cap2.91B
Zai Lab Limited is involved in discovering, developing, and commercializing a broad range of healthcare and pharmaceutical products, overlapping with CDBT's market in biotechnological healthcare solutions.
Sinovac Biotech
SVA
Mkt Cap642.44M
Sinovac Biotech Ltd. specializes in the research, development, manufacturing, and commercialization of vaccines, competing in the biotech sector focused on healthcare and medical treatments.
Wuxi AppTec.
WUXAY
Mkt Cap41.71B
WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech, and medical device industries to advance discoveries and deliver groundbreaking treatments, directly competing with CDBT's services.
Can-Fite Biopharma
CANF
Mkt Cap15.35M
Can-Fite BioPharma Ltd. is a biotechnology company developing drugs with an emphasis on cancer, making it a competitor in the biotech industry focused on innovative treatments.
Hologic
HOLX
Mkt Cap16.45B
Hologic, Inc. specializes in diagnostics, medical imaging systems, and surgical products, especially for women's health, competing with CDBT in the broader healthcare and biotech market.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet medical need, competing in the biotech and healthcare sector.
AMGEN
AMGN
Mkt Cap160.66B
Amgen Inc. is one of the world's leading biotechnology companies, focusing on areas such as cardiovascular disease, oncology, bone health, neuroscience, nephrology, and inflammation, competing across several of CDBT's operational areas.
Pfizer
PFE
Mkt Cap140.15B
Pfizer Inc. is a global pharmaceutical corporation which develops and produces medicines and vaccines for a wide range of medical disciplines, including those covered by CDBT's biotechnological research and development.
Moderna
MRNA
Mkt Cap10.61B
Moderna, Inc. focuses on mRNA-based therapeutics and vaccines, competing in the innovative biotech sector where CDBT also aims to make its mark with biotechnological advancements and healthcare solutions.

About

China Dasheng Biotechnology Company, together with its subsidiaries, engages in the production, marketing, and distribution of bacteria based products used as additives for livestock feed and crop cultivation in the People's Republic of China. It provides artificial microorganisms (AM) and high-efficiency microorganism (HM) based biological bacterium blends; and biological preservatives. The company offers AM/HM bacteria based additives for crops, including Bulgaria lactobacillus, beer microzyme, and dark red spirilla used to increase the beneficial microorganism colonies in soil; inhibit the reproduction of harmful fungi and putrefactive bacteria; and to improve nutrient absorption and reduce crop and livestock diseases. It also provides AM/HM bacteria based additives for livestock feed, which softens the livestock feed and restrain the growth and reproduction of pathogenic bacteria, as well as supplies beneficial nutriments, including organic acid, vitamins, enzyme, antibiotics, mycelium protein, and other growth-enhancing substances that balance the nutrients in the feed. In addition, the company offers FGW bacterial based preservatives that preserve animal specimens for scientific research; and preserve the freshness for agricultural produce. Further, it provides bacteria based fertilizer for application on plants, such as vegetable and fruit leaves. Additionally, China Dasheng Biotechnology Company engages in residential and commercial real estate investment. The company was formerly known as Max Nutrition, Inc. and changed its name to China Dasheng Biotechnology Company in March 2008. China Dasheng Biotechnology Company is based in Lanzhou, China.
Show more...
CEO
Mr. Jinjun Qi
Employees
689
Country
US
ISIN
US23255X1019

Listings

0 Comments

Share your thoughts

FAQ

What is Cycclone stock price today?
The current price of CYCL is $0.04 USD — it has increased by +83.5% in the past 24 hours. Watch Cycclone stock price performance more closely on the chart.
What is Cycclone stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Cycclone stocks are traded under the ticker CYCL.
Is Cycclone stock price growing?
CYCL stock has risen by +0% compared to the previous week, the month change is a -0.27% fall, over the last year Cycclone has showed a -37.8% decrease.
What is Cycclone market cap?
Today Cycclone has the market capitalization of 1.5M
What is Cycclone revenue for the last year?
Cycclone revenue for the last year amounts to 0 USD.
What is Cycclone net income for the last year?
CYCL net income for the last year is 1.57M USD.
Does Cycclone pay dividends?
Yes, CYCL dividends are paid en. The last dividend per share was 5.52 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Cycclone have?
As of April 02, 2026, the company has 689 employees.
In which sector is Cycclone located?
Cycclone operates in the Financials sector.
When did Cycclone complete a stock split?
The last stock split for Cycclone was on January 21, 2000 with a ratio of 3:1.
Where is Cycclone headquartered?
Cycclone is headquartered in Lanzhou, US.